# Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes

> **NCT03728049** · NA · UNKNOWN · sponsor: **University Hospital, Lille** · enrollment: 944 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Aortic Valve Insufficiency

## Interventions

- **DIAGNOSTIC_TEST:** CT-ADP performed during TAVI procedure
- **OTHER:** No CT-ADP performed during TAVI procedure

## Key facts

- **NCT ID:** NCT03728049
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-18
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 944 (ESTIMATED)
- **Last updated:** 2023-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03728049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03728049, "Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03728049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*